A shot in the arm for vaccine research
New vaccines could be developed more quickly and be better targeted to specific age groups, thanks to the EU-funded research project ADITEC. This five-year long project has been studying novel immunisation technologies, boosting international efforts in vaccine research. To fulfil its broad mission, the project consortium comprises 42 partners, including the World Health Organization, research institutes, companies, small and medium sized enterprises and non-profit organisations.
The ADITEC project has increased our knowledge on how our bodies respond to vaccines and vaccine components. Specific results so far, such as novel immunisation technologies, adjuvants, vectors and delivery systems, optimised formulations and vaccination methods for different age groups, all come together in a toolbox enabling the best possible insight into fighting diseases. The project is also contributing to possible international regulation and standards for these novel technologies.